Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Neuland Laboratories Limited

Market Cap 223B 2.36B 2.06B 1.9B 1.78B 3.34B 3.36B 22.6B 8.76B 110B 8.86B 8.67B 380B P/E 2026
42.3x
P/E 2027 * 53.1x
Enterprise Value 222B 2.36B 2.06B 1.9B 1.78B 3.34B 3.36B 22.59B 8.75B 110B 8.85B 8.66B 380B EV / Sales 2026
7.59x
EV / Sales 2027 * 9.4x
Free-Float
62.24%
Yield 2026
0.28%
Yield 2027 * 0.08%
1 day+0.80%
1 week+1.00%
Current month+1.65%
1 month+4.35%
3 months+44.52%
6 months+7.98%
Current year+14.22%
1 week 16,569.95
Extreme 16569.95
17,520.9
1 month 16,400
Extreme 16400
17,650
Current year 11,500
Extreme 11500
18,379.95
1 year 11,500
Extreme 11500
19,748.4
3 years 2,730
Extreme 2730
19,748.4
5 years 965.85
Extreme 965.85
19,748.4
10 years 247.3
Extreme 247.3
19,748.4
Manager TitleAgeSince
Chief Executive Officer 46 2026-03-31
Director of Finance/CFO - 2022-11-22
Chief Tech/Sci/R&D Officer - 2023-02-28
Director TitleAgeSince
Director/Board Member 50 2001-12-31
Chairman 82 1984-01-06
Director/Board Member 46 2007-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%+1.00%+41.88%+494.43% 2.36B
-1.21%-3.04%+44.03%+142.51% 980B
-2.48%-5.18%+52.47%+39.36% 550B
-2.14%-4.94%+16.83%+58.18% 382B
+0.25%-3.09%+23.33%+16.78% 316B
+0.61%-1.69%+27.35%+14.22% 272B
+0.22%-3.10%+24.67%+30.69% 268B
+4.59%+1.98%-38.43%-46.41% 199B
-1.19%-4.95%+16.68%+48.70% 182B
-1.35%-1.46%+14.06%+59.46% 154B
Average -0.19%-2.61%+22.29%+85.79% 330.47B
Weighted average by Cap. -0.78%-3.67%+29.50%+63.80%

Financials

2026 2027 *
Net sales 17.64B 187M 163M 151M 141M 265M 267M 1.79B 694M 8.68B 702M 687M 30.14B 23.33B 247M 216M 200M 187M 351M 353M 2.37B 918M 11.48B 928M 908M 39.87B
Net income 2.57B 27.27M 23.77M 22.02M 20.61M 38.65M 38.89M 261M 101M 1.27B 102M 100M 4.4B 4.21B 44.61M 38.9M 36.02M 33.72M 63.24M 63.63M 427M 166M 2.07B 167M 164M 7.19B
Net Debt -117M -1.23M -1.08M -997K -933K -1.75M -1.76M -11.83M -4.58M -57.35M -4.63M -4.54M -199M -3.18B -33.75M -29.43M -27.25M -25.51M -47.85M -48.14M -323M -125M -1.57B -127M -124M -5.44B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
1,794
Date Price Change Volume
26-06-19 17,349.60 +0.80% 898
26-06-18 17,211.95 +1.25% 1,124
26-06-17 16,999.75 +1.71% 1,208
26-06-16 16,713.95 -1.96% 1,218
26-06-15 17,048.95 -0.75% 1,945
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
17,349.60INR
Average target price
20,972.00INR
Spread / Average Target
+20.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!